Intraday Trading: Top Stocks Today

**Previous Session's Market Performance**

Commencing with a positive note, the market traversed within a narrow range of 21940-22080 during the entirety of the previous session. Ultimately, it surged to a gratifying conclusion, with the Nifty closing higher by 0.79 percent.

In contrast to the Nifty 50, the Nifty Midcap 100 index triumphed, registering a substantial gain of 2.43 percent. Among the various sectors, Metals and Realty emerged as pioneers, showcasing remarkable strength. Conversely, FMCG and IT encountered challenges and underperformed throughout the session.

An analysis of the options market reveals a convergence of open interest for both call and put sides at the strike price of 22000. A closer examination of today's option chain suggests higher put writing activity relative to call writing, indicating a bullish sentiment.

For the current session, the Volume Weighted Average Price (VWAP) delineates a trading range between 21895 and 22190. The Max Pain rests at 21850 spot, with the combined CE/PE Residual Premium/Pain Value amounting to 248.69 Crores.

In the cash market, Foreign Institutional Investors (FIIs) executed net sales totaling 1826.97 crore, while Domestic Institutional Investors (DIIs) actively purchased stocks for a net amount of 3208.87 crore.

Top Stocks to Buy Today:

1) AUROPHARMA

Buy AUROPHARMA shares in intraday timeframe at CMP Rs. 1031.75

2) ZENSARTECH

Buy ZENSARTECH shares in intraday timeframe at CMP Rs. 580.85

3) VMART

Buy VMART shares in intraday timeframe at CMP Rs. 2005

4) POONAWALLA

Buy POONAWALLA shares in intraday timeframe at CMP Rs. 467.35

Top Stocks to Short Today:

1) BDL

Sell BDL shares in intraday timeframe at CMP Rs. 1687.95

2) AARTIDRUGS

Sell AARTIDRUGS shares in intraday timeframe at CMP Rs. 450.5

3) GLAND

Sell GLAND shares in intraday timeframe at CMP Rs. 1765.95

4) LUXIND

Sell LUXIND shares in intraday timeframe at CMP Rs. 1115.05

Disclaimer: Remember, the market is a living beast, and even the most informed predictions can be devoured by unforeseen events. While this analysis is based on a thorough rule-based research, the ultimate decision to buy or sell rests with you. Do your own due diligence, consider your risk tolerance, and craft a strategy that aligns with your financial goals. Stratzy provides insights, not guarantees, and cannot be held responsible for any gains or losses incurred in your trading activities. Invest wisely, trade responsibly, and may the market gods favor you!